✦ LIBER ✦

PDB18 A COMPARISON OF COSTS AMONG PATIENTS WITH TYPE 2 DIABETESWHO INITIATED THERAPY WITH EXENATIDE OR SITAGLIPTIN

✍ Scribed by MJ Lage; DA Misurski; R Fabunmi; KS Boye

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB17 A COMPARISON OF COSTS AMONG PATIEN

✍ DA Misurski; R Fabunmi; KS Boye; MJ Lage 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

PDB7 ADMINISTRATIVE CLAIMS ANALYSIS OF P

✍ R Fabunmi; R Wade; RA Quimbo; L Hou; MD Pawaskar; D Misurski 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PDB83 TIME TO TREATMENT MODIFICATION AMO

✍ M Pawaskar; M Bonafede; BH Johnson; R Fowler; B Hoogwerf 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB58 CHANGES IN CONCOMITANT DIABETES TH

✍ D Misurski; A Oglesby; R Wade; R Quimbo; B Schroeder; M Wintle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB18 COST OFFSETS ASSOCIATED WITH USE O

✍ MD Pawaskar; J Anderson; AJ Zagar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PDB52 Adherence: A Real World Retrospect

✍ Maria, M.; Carlqvist, P.; Langer, J.; Bouchard, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB